Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

15 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasms.
Murphy WM, Soloway MS, Jukkola AF, Crabtree WN, Ford KS. Murphy WM, et al. Among authors: jukkola af. Cancer. 1984 Apr 1;53(7):1555-65. doi: 10.1002/1097-0142(19840401)53:7<1555::aid-cncr2820530723>;2-g. Cancer. 1984. PMID: 6697294
The diagnostic value of urine versus bladder washing in patients with bladder cancer.
Murphy WM, Crabtree WN, Jukkola AF, Soloway MS. Murphy WM, et al. Among authors: jukkola af. J Urol. 1981 Sep;126(3):320-2. doi: 10.1016/s0022-5347(17)54505-x. J Urol. 1981. PMID: 7277589
Bladder histological changes associated with chronic indwelling urinary catheter.
Delnay KM, Stonehill WH, Goldman H, Jukkola AF, Dmochowski RR. Delnay KM, et al. Among authors: jukkola af. J Urol. 1999 Apr;161(4):1106-8; discussion 1108-9. J Urol. 1999. PMID: 10081848
Recurrent dense deposit disease in renal allograft.
Jukkola AF, Mantaring T, Roy S 3rd, Murphy WM. Jukkola AF, et al. Urology. 1978 Apr;11(4):395-7. doi: 10.1016/0090-4295(78)90241-8. Urology. 1978. PMID: 351916
Intraluminal shunt for the thoracic aorta: blood flow and function in chronic studies.
Van Voorst SJ, Labranche GS, Rustom S, Jukkola AF, Leffler CW. Van Voorst SJ, et al. Among authors: jukkola af. Ann Thorac Surg. 1997 Feb;63(2):419-24. doi: 10.1016/s0003-4975(96)00899-5. Ann Thorac Surg. 1997. PMID: 9033312
Aggressive breast cancer leads to discrepant serum levels of the type I procollagen propeptides PINP and PICP.
Jukkola A, Tähtelä R, Thölix E, Vuorinen K, Blanco G, Risteli L, Risteli J. Jukkola A, et al. Cancer Res. 1997 Dec 15;57(24):5517-20. Cancer Res. 1997. PMID: 9407961
Lymphoma mimicking carcinoma erysipeloides.
Khan BQ, Gandhi MS, Edmonds H, Ahmad K, Rasberry RD, Corbett C, Jukkola AF, Carbone LC. Khan BQ, et al. Among authors: jukkola af. Int J Dermatol. 2008 Mar;47(3):269-71. doi: 10.1111/j.1365-4632.2008.03474.x. Int J Dermatol. 2008. PMID: 18289330 No abstract available.
Elevated preoperative serum levels of collagen I carboxyterminal telopeptide predict better outcome in early-stage luminal-B-like (HER2-negative) and triple-negative subtypes of breast cancer.
Jääskeläinen A, Jukkola A, Risteli J, Haapasaari KM, Karihtala P. Jääskeläinen A, et al. Tumour Biol. 2019 May;41(5):1010428319847081. doi: 10.1177/1010428319847081. Tumour Biol. 2019. PMID: 31122159
Adverse outcome and resistance to adjuvant antiestrogen therapy in node-positive postmenopausal breast cancer patients-The role of p53.
Rahko E, Blanco G, Bloigu R, Soini Y, Talvensaari-Mattila A, Jukkola A. Rahko E, et al. Breast. 2006 Feb;15(1):69-75. doi: 10.1016/j.breast.2005.04.004. Epub 2005 Jul 7. Breast. 2006. PMID: 16005229 Clinical Trial.
Matrix metalloproteinase-9 (MMP-9) immunoreactive protein has modest prognostic value in locally advanced breast carcinoma patients treated with an adjuvant antiestrogen therapy.
Rahko E, Jukkola A, Melkko J, Paavo P, Bloigu R, Talvensaari-Mattila A, Turpeenniemi-Hujanen T. Rahko E, et al. Anticancer Res. 2004 Nov-Dec;24(6):4247-53. Anticancer Res. 2004. PMID: 15736480
15 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page